Evidence map›Paper›PMID 40463699›Full record

ArticleArXiv2025

A Comparative Study of Transformer-Based Models for Multi-Horizon Blood Glucose Prediction.

Meryem Altin Karagoz, Marc D Breton, Anas El Fathi

Abstract readPreprint
In one paragraph

Article in ArXiv, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Meryem Altin KaragozCenter for Diabetes Technology, the University of Virginia, Charlottesville, VA, USA.
Marc D BretonCenter for Diabetes Technology, the University of Virginia, Charlottesville, VA, USA.
Anas El FathiCenter for Diabetes Technology, the University of Virginia, Charlottesville, VA, USA.

Funding

ADAPTIVE MOTIF-BASED CONTROL (AMBC): A FUNDAMENTALLY NEW APPROACH TO AUTOMATED TREATMENT OPTIMIZATION FOR TYPE 1 DIABETESR01DK133148 · NIDDK · UNIVERSITY OF VIRGINIA · PI SUE A BROWN, BORIS P KOVATCHEV · 2022 to 2026
$3.4M
NIDDK NIH HHS R01 DK133148
6 · The paper itself

Abstract

Accurate blood glucose prediction can enable novel interventions for type 1 diabetes treatment including personalized insulin and dietary adjustments. Although recent advances in transformer-based architectures have demonstrated the power of attention mechanisms in complex multivariate time series prediction, their potential for blood glucose (BG) prediction remains underexplored. We present a comparative analysis of transformer models for multi-horizon BG prediction, examining forecasts up to 4 hours and input history up to 1 week. The publicly available DCLP3 dataset (n=112) was split (80%-10%-10%) for training, validation, and testing, and the OhioT1DM dataset (n=12) served as an external test set. We trained networks with point-wise, patch-wise, series-wise and hybrid embeddings, using CGM, insulin, and meal data. For short-term blood glucose prediction, Crossformer, a patch-wise transformer architecture, achieved a superior 30 minute prediction of RMSE (15.6 mg / dL on OhioT1DM). For longer-term predictions (1h, 2h, and 4h) PatchTST, another path-wise transformer, prevailed with the lowest RMSE (24.6 mg/dL, 36.1 mg/dL, and 46.5 mg/dL on OhioT1DM). In general, models that used tokenization through patches demonstrated improved accuracy with larger input sizes, with the best results obtained with a one-week history. These findings highlight the promise of transformer-based architectures for BG prediction by capturing and leveraging seasonal patterns in multivariate time-series data to improve accuracy.

Indexed as

continuous glucose monitoringglucose forecastingtransformerstype 1 diabetes

Identifiers

PMID40463699
PMCPMC12132272

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.